Indeed, treatment with as little as 1 nM of PLK1 siRNA was able to reduce PLK1 protein expression and cell proliferation in both H1299 and Calu-6 NSCLC cell lines when compared to controls (Supplementary Figure 2A-D). The gene discussed is PLK1; the disease is non-small cell lung carcinoma.